TANG KEVIN bought BOLD

October 19, 2026 · Form 4 insider transaction

TANG KEVIN bought 12,790 shares of Boundless Bio, Inc. at $2.34 per share, a transaction worth $29.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
12,790
Price
$2.34
Total value
$29.9K
InsiderTANG KEVIN
RoleOfficer, Director, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 19, 2026
Filing dateOctober 20, 2026
Shares owned after2,971,610
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The Reporting Persons have delivered to the Issuer the full amount of the disgorgeable profit arising the purchases reported herein, in the amount of $1,723.10.; These shares were purchased in multiple transactions at prices ranging from $2.31 to $2.35.; Tang Capital Partners, LP ("TCP") beneficially owns 688,494 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 937,213 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 688,487 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 675,915 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.

View the original Form 4 on SEC EDGAR